The patent litigation relates to the companies’ continuous glucose monitor (CGM) technologies. Abbott and Dexcom are two ...

The FDA has issued a warning letter related to BD Pyxis automated medication dispensing systems — technology that was part of ...

There has been no shortage of news covered across the diabetes and drug delivery markets over the course of 2024.

Vivani Medical (Nasdaq:VANI) announced today that it initiated screening and enrollment for a first-in-human trial of its GLP ...

Dexcom (Nasdaq:DXCM) announced today that it launched a proprietary generative AI platform integrated with its glucose ...

Eli Lilly (NYSE:LLY) announced today that the Egyptian Drug Authority approved insulin glargine manufactured in partnership ...

The MODD1 insulin pump. [Image from Modular Medical] Modular Medical (Nasdaq:MODD) announced recently that it priced an underwritten public offering worth proceeds of around $8.2 million. The San ...

Left, the Dexcom G7 CGM. Right, the Abbott FreeStyle Libre 2. [Images from Dexcom and Abbott] The Unified Patent Court in Paris sided with Abbott (NYSE:ABT) following a CGM patent infringement claim ...